And thats close to 1billion syringes if I am not mistaken - growing at 15-25% per year. By the time the production facility is complete, it will not be able to supply 100% of Sanofi's requirements for RTFS. So I expect a much bigger extension further down the track (which is not a part of the current plans)
Sanofi should provide 50% of Unilife's revenue. The others will contribute the other $1billion+